Results 81 to 90 of about 672 (125)

[Results of heterologous artificial insemination, ethical- deontological implications].

Polski tygodnik lekarski (Warsaw, Poland : 1960), 1989
Fourteen female patients married to infertile men were artificially inseminated with the semen of unknown donors within 1985-1987. Over 150 inseminations (no complications except sporadic pain) produced 7 pregnancies out of which 5 were finished with the delivery of healthy babies, one was terminated in the seventh week with abortion.
M, Medraś, K, Blok, L, Terpiłowski
openaire   +1 more source

[Heterologous artificial insemination (author's transl)].

Geburtshilfe und Frauenheilkunde, 1980
The indications for insemination, the selection of donor, consultation with the recipient parent and the technique will be described, based on our four-year experience. A description of the examination before the insemination and the results from a small collection of cases will be discussed.
openaire   +1 more source

[Simultaneous occurrence of bilateral extrauterine pregnancy and ovarian hyperstimulation syndrome following artificial heterologous insemination (differential diagnostic difficulties)].

Orvosi hetilap, 1990
Simultaneous occurrence of bilateral extrauterine pregnancy and hyperstimulation syndrome of the ovary following artificial heterologous insemination, meaning difficulty in the differential diagnosis, is described. In connection with the case the protocol of induction of ovulation used regularly by the authors is presented and the necessary monitoring ...
G, Ugocsai, J, Szöllösi, G, Godó
openaire   +1 more source

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Lancet, The, 2021
Sue Charlton, Andrea M Collins, Saul N Faust   +2 more
exaly  

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine, 2022
Robert L Atmar, Kirsten E Lyke, Meagan Bolles   +2 more
exaly  

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Lancet, The, 2022
Lily Yin Weckx, Wanwisa Dejnirattisai, Juthathip Mongkolsapaya   +2 more
exaly  

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Nature Medicine, 2021
Tina Schmidt, David Schub, Janine Mihm
exaly  

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

Science, 2022
Catherine J Reynolds, Joseph M Gibbons, Corinna Pade   +2 more
exaly  

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Lancet, The, 2022
Andrea M Collins, Saul N Faust, Daniela M Ferreira   +2 more
exaly  

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination

Nature Medicine, 2022
Carolina Lucas, Valter Vinicius Silva Monteiro, Chantal B F Vogels   +2 more
exaly